Literature DB >> 15331853

Long-term growth hormone therapy in mitochondrial cytopathy.

Salvatore Barberi1, Elena Bozzola, Angela Berardinelli, Cristina Meazza, Mauro Bozzola.   

Abstract

OBJECTIVE: To describe in a 5-year-old Caucasian male with mitochondrial cytopathy, a biochemical growth hormone (GH) deficiency associated with normal GH biological activity as evaluated by Nb2 cell bioassay and normal serum IGF-I and IGFBP3 values increasing slightly after GH administration.
METHOD: Serum GH concentrations were measured with a commercial immunofluorometric assay and with a biological assay, which uses the Nb2 cell line. Serum IGF-I and IGFBP3 concentrations were measured with RIA.
RESULTS: The GH-supplementary therapy was initially effective in terms of growth gain, but no therapeutic benefit was observed over a long period of time.
CONCLUSION: In patients suffering from mitochondrial cytopathy, short stature seems to be attributed more to a disease-related inadequate protein substrate than to the non-classical GH deficiency.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15331853     DOI: 10.1159/000080451

Source DB:  PubMed          Journal:  Horm Res        ISSN: 0301-0163


  4 in total

1.  Skeletal muscle mitochondrial function is associated with longitudinal growth velocity in children and adolescents.

Authors:  Shana E McCormack; Meaghan A McCarthy; Loredana Farilla; Mirko I Hrovat; David M Systrom; Steven K Grinspoon; Amy Fleischman
Journal:  J Clin Endocrinol Metab       Date:  2011-08-10       Impact factor: 5.958

Review 2.  Mitochondrial disease and endocrine dysfunction.

Authors:  Jasmine Chow; Joyeeta Rahman; John C Achermann; Mehul T Dattani; Shamima Rahman
Journal:  Nat Rev Endocrinol       Date:  2016-10-07       Impact factor: 43.330

3.  Height as a Clinical Biomarker of Disease Burden in Adult Mitochondrial Disease.

Authors:  Rachel L Boal; Yi Shiau Ng; Sarah J Pickett; Andrew M Schaefer; Catherine Feeney; Alexandra Bright; Robert W Taylor; Doug M Turnbull; Grainne S Gorman; Tim Cheetham; Robert McFarland
Journal:  J Clin Endocrinol Metab       Date:  2019-06-01       Impact factor: 5.958

4.  Endocrine Manifestations and New Developments in Mitochondrial Disease.

Authors:  Yi Shiau Ng; Albert Zishen Lim; Grigorios Panagiotou; Doug M Turnbull; Mark Walker
Journal:  Endocr Rev       Date:  2022-05-12       Impact factor: 25.261

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.